| Date Filed | Type | Description |
| 02/12/2020 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 0% stake in GENOMIC HEALTH, INC. |
| 11/18/2019 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 11/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/13/2019 |
SC 13G
| ICS OPPORTUNITIES, LTD. reports a 0% stake in GENOMIC HEALTH, INC. |
| 11/13/2019 |
SC 13D/A
| EXACT SCIENCES CORP reports a 100% stake in GENOMIC HEALTH, INC. |
| 11/08/2019 |
8-K
| Resignation/termination of a director |
| 11/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/08/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 11/08/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 11/08/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/07/2019 |
8-K
| Quarterly results |
| 10/30/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 10/29/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/29/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/28/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/28/2019 |
8-K
| Quarterly results |
| 10/28/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/28/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/04/2019 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 09/23/2019 |
GN
| SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies Is Fair to Shareholders – AGN, ORIT, MCRN, GHDX |
| 09/17/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – LTXB, MCRN, GHDX, NCI |
| 09/11/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/11/2019 |
8-K
| Quarterly results |
| 09/09/2019 |
GN
| Shareholder Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – UBNK, TYPE, GHDX, NCI |
| 09/04/2019 |
GN
| SRCI, WAIR, NRE, and GHDX SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
| 09/03/2019 |
GN
| Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – MCRN, TYPE, GHDX, CBM |
| 08/15/2019 |
GN
| CDOR, GHDX, TYPE, and UBNK SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Acquisitions |
| 08/14/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders – UBNK, TYPE, GHDX, NCI |
| 08/12/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
|